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Effect of Antibody Orientation on Immunosorbent
Performance
Anuradha Subramanian and William H. Velander*
ABSTRACT: 
The impact of antibody orientation on immunosorbent efficiency was quantitatively assessed. A pH-dependent murine monoclonal 
antibody (Mab) against human protein C (hPC), recombinant hPC (rhPC) and two different immobilization chemistries and matrices 
were used as model systems. The lysyl groups of the rhPC were covalently modified with an acetic acid ester of N-
hydroxysuccinimide and this modified rhPC was used as a Fab masking agent (FMA). The FMA was used to mask the antigen 
binding regions (Fab) of the Mab prior to and during covalent immobilization. Thereafter, the residual active sites of the support were 
inactivated and the FMA was removed. Mab was immobilizeed at low bead-averaged densities of about 0.4-1.1 mg Mab/mL matrix 
to minimize local density effects. Immunosorbents made using masked Mab (oriented coupling) gave antigen binding efficiencies 
(nAgo) f 4248% compared with 18-22% for those made by random coupling. The amount of (Fab), released from pepsin digestion of 
immuncsorbents was about --fold higher for matrices having been made with FMA-masked Mab relative to unmasked Mab. Thus, 
the (Fab), accessibility to pepsin correlates well with higher functional efficiency (nAJ and serves as a measure of orientation. In 
summary, at low Mab density and a 2:l molar rhPC to Mab binding stoichiometry, about 80% or more of the Mab randomly coupled 
through amino moieties was improperly oriented relative to oriented coupled Mab, which correlated with about 50% of lost Mab 
functionality upon immobilization.
Keywords: antibody orientation; immunosorbent performance
Introduction
Immunoaffinity-based methods can be used as an 
efficient and high-resolution step for protein purification
(Tar nowsky and Liptak, 1983; Tarnowsky et al., 1986). The 
customized avidity of the parent antibody for a given 
target molecule can make immunoaffinity chromatography 
a versatile tool for purifiying closely related proteins in a 
biologically active form (Orthner et al., 1989; Velander et 
al., 1989). However, the use of immunosorbents on a 
large scale is frequently precluded by high capital costs. 
These costs can mostly be associated with the low 
functional activity of immobilized antibodies and the 
development and production costs of pathogen-free 
antibody having a desired specificity for therapeutic 
applications (Orthner et al., 1989; Velander et al., 1990). 
Typically, antigen binding efficiencies of 3-15% are 
obtained for monoclonal immunosorbents containing 1-10 
mg of antibody/mL of support (Eveleigh
and Levy, 1977; Wilchek et al., 1984; Hearn, 1986; Strauss
et al., 1987; Subramanian et al., 1994). Immunoglobulins 
(IgGs) are glycoproteins with an approximate molecular 
weight of 150000Da. The nonantigen binding domain of 
an IgG is known as the Fc region and has a cell receptor 
function which is independent of the antigen binding 
domain and function. IgGs have two identical disulfide-
linked, antigen combining sites known as the Fab 
domains which contain a highly variable sequence to 
provide antigen binding specificity (Stryer, 1980). IgGs
can be enzymatically cleaved by pepsin to give an intact
(Fab), from the Fc domain (Stryer, 1980; Goding, 1983).
Author to whom correspondence should be addressed. The targeted 
binding by protein A and G to the Fc domain has been 
utilized to anchor Mabs (Schneider et al., 1982). The 
variable avidity of protein A and G with different IgG
subclasses, protein leaching from the matrix and reagent
costs make this sandwich anchoring method less 
amenable to large-scale applications. Alternatively, Fc-
specific coupling chemistry which uses hydrazide-based 
activation to oxydize carbohydrate on the Mab has been 
developed (Hearn, 1986; O’Shanessey and Hoffmann, 
1987; Little et al., 1988; Domen et al., 1990; Fleminger et 
al., 1990; Bonde et al., 1991). However, carbohydrate also 
occurs in the Fab domains and Mabs immobilized on 
matrices using hydrazide chemistry did not produce 
significant differences in Mab functional efficiency 
compared with random immobilization by CNBr chemistry 
(Orthner et al., 1991). The performance of an 
immunosorbent is strongly dependent on intraparticle 
transport, adsorption/desorption kinetics of the Mab 
(Kaster et al., 1993) and on the molecular orientation 
(Orthner et al., 1991; Velander et al.,
1992) and local density of the immobilized antibody
(Subramanian et al., 1994). It has long been hypothesized
that optimum binding kinetics for antigen binding requires
the right orientation and spacing of the immobilized
antibody (Velander et al., 1992). Although immunosorbent
efficiency is most often characterized on a volume or 
bead averaged basis, antibody spacing can be a strong 
function of position and a high local density greatly 
decreases immunosorbent efficiency (Subramanian et al., 
1994). Multipoint attachment of the antibody to the support 
matrix may also have a negative effect on immunosorbent 
efficiency and about a 3-1 1-fold increase in 
immunosorbent activity was observed for immobilized 
Mabs having reactive NH. 
EFFECT OF ANTIBODY ORIENTATION ON IMMUNOSOREJENT 
PERFORMANCE 
moieties protected by dimethylmaleic anhydride (Strauss 
et
al., 1987; Hadas et al., 1990). We have previously 
demonstrated that shielding of the Fab domains of Mabs 
during the immobilization process results in greater 
relative immunosorbent efficiency and Fab accessibility in 
a membrane-based, enzyme-linked immunosorbent
assay (ELISA) system (Velander et al., 1992). In the
present study, we used a lysyl-modified recombinant
antigen to mask quantitatively the Mab prior to and during
immobilization to chromatographic matrices. Thus, the
FMA has been used here as a tool both to quantitatively
probe and to engineer Mab orientation in immunosorbents
used for purification.
Materials and Methods
Materials
A murine pH-dependent anti-hPC Mab (8861-Mab) was
provided by American Red Cross (Rockville, MD). Rabbit
antisera against hPC, affinity-purified goat-anti-mouse
(whole molecule) and anti-goadanti-mouse 
immunoglobulins conjugated to horseradish peroxidase 
(HRP) were purchased from Sigma Chemical (St Louis, 
MO). Goat antihPC antisera was purchased from 
American Diagnostics (Greenwich, CT). Emphaze AB 1 
biosupport medium was provided by 3M (Minneapolis, 
MN) and Affiprep polymeric support was purchased from 
Bio-Rad Laboratories (Anaheim, CA). Immulon I1 
microtiter plates were purchased from Fisher Scientific 
(Pittsburgh, PA). The hPC was provided by American Red 
Cross. The rhPC was isolated from transgenic porcine 
whey using immunoaffinity chromatography (Morcol et al., 
1994).
o-Phenylenediamine-dihydrochloride 
(OPD) tablets were purchased from Abbott Laboratories 
(Chicago, IL). The Nsuccinimide ester of acetic acid and 
trinitrobenzenesulfonic acid (TNBS) were purchased from 
Sigma Chemical. All other reagents were purchased from 
Sigma Chemical as the best grade available. 
Immunoaffinity separations were performed with 
Phannacia C-10 columns (15 cmx 1 cm i.d.), a Masterflex 
peristaltic pump and a Knauer spectrophotometer and a 
Rainin data acquisition system were used to monitor 
chromatography. Columns were kept at 4°C with a Lauda 
Super RMT water cooler.
Synthesis of FMA from recombinant hPC
The reactive amino moieties on the rhPC were covalently
modified using an acetic acid ester of N-
hydroxysuccinimide (Endo et al., 1987). A 3 mg/mL 
solution of rhpC in borate buffer (0.05 M borate, 0.14 M 
NaCl, pH 8.6) was slowly mixed with 10 & of a 200 molar 
excess of ester in dimethylformamide. The pH of the 
reaction was maintained at 8.5 by the addition of 1 M 
NaOH and the reaction was allowed to proceed for 24 h 
at 4°C. The unreacted ester was quenched by adding a 
40 molar excess of glycine using a 0.4 M glycine stock 
solution at pH 8.5. After 4 h of stirring, the modified 
protein solution was extensively dialyzed against 
phosphate-buffered saline (PBS) (50 t n ~sod ium
phosphate, 100m NaCl, pH 7.0)’ for 24 h to yield a
protein-ester conjugate. The degree of modification of the
amino residues on rhPC was determined by TNBS assay
(Snyder and Sobocinski, 1975).
Preparation of unmasked and FMA-masked
Immunosorbent
Affi-prep is a polymeric support with reactive ester groups 
which react with NH2 groups on proteins to give stable
amide linkages. Affi-prep was washed with 10 m~ sodium
acetate buffer (pH 4.5) according to the manufacturer’s
instructions and was suspended as a 50% (v/v) slurry in 
the coupling buffer, 0.1 M MOPS, 0.15 M NaCl (pH 7.2). 
Figure 1 shows the preparation of an rhPC-FMA-masked 
immunosorbent. For the preparation of an FMA-masked
immunosorbent, each of two replicate support solutions
containing 1 mg of Mab was incubated with 2.4mg of
rhPC-FMA (6:l molar ratio) for 2 h at room temperature
(RT). In the case of the unmasked immunosorbent, Mab 
was incubated with coupling buffer for the same period of 
time.
The supernatant was pipetted from the top of the resin 
and FMA-Mab solution was added to the tubes and the 
slurry was rotated overnight at 4°C. Upon completion of 
the coupling reaction, the gel was allowed to settle and 
the supernatant was pipetted and saved for ELISA. The 
residual active sites on the resin were blocked with 1.0 M 
ethanolamine for 1 h at 4°C after which the supernatant 
was drawn and saved €or ELISA. The gel was washed in 
a column mode with 0.05 M Tris, 0.1 M NaCl (pH 7.0) until 
the absorbance of the column effluent dropped to zero. 
The FMA-Mab complex was disrupted with 2 M NaSCN. 
The column was washed with all the buffer systems to be
employed in the actual chromatographic run and the
fractions were saved for Mab leakage determination. The
columns were stored in the protein coupling buffer at 4°C.
Emphaze AB 1 (dp=60 pm) is a polymer-based, rigid and
macroporous beaded affinity support for bioseparations
(Coleman et al., 1990). Emphaze AB 1 contains an 
azlactone functionality which readily undergoes a ring-
opening reaction with amines to yield stable covalent 
linkages. Mabs were immobilized on Emphaze AB1 
according to the manufacturer’s instructions. Briefly, each 
replicate treatment consisted of 125 mg of azlactone 
beads suspended in 1.0 mL of coupling buffer containing 
0.5 mg of 8861-Mab and 1.2 mg of rhPC-FMA (6: 1 molar 
ratio) to yield 1 .O mL of affinity sorbent. On completion of 
the Mab immobilization step, blocking and washing steps 
similar to those described above were performed.
Determination of Mab bound
The amounts of Mab in feed and coupling step 
supernatants and washes were determined by the ELISA 
procedure outlined by Subramanian et aZ., 1994).
Breakthrough Analysis
Breakthrough analysis of FMA-masked and unmasked
immunosorbents were performed according to the 
procedure outlined by Subramanian et al. (1994). Each 
column was subjected to three consecutive 
chromatographic runs.
Figure 1.
Preparation of FMA-masked immunosorbent. Mab was incubated with 
FMA in solution prior to covalent immobilization. FMA-Mab complexes 
were then incubated with an activated matrix. Unreacted active sites on 
the matrix were inactivated and the FMA was eluted from the Mab to 
yield an oriented immobilized Mab.
Determination of protein C in feed and column eluates
The amount of rhPC antigen was determined by the 
ELISA
procedure outlined by Subramanian et al. (1994).
Pepsin digestion of immobilized Mab
A 200pL of a 50% (v/v) slurry of FMA-masked or
unmasked immunosorbent was pipetted into screw-
capped tubes in replicates to yield a final immunosorbent 
volume of 100 pL. The immunosorbents were washed 
four times with 0.1 M sodium citrate (pH 4.2) and 
suspended in 100 pL of citrate buffer. A 10 pL volume of a 
10 mg/mL solution of pepsin in 0.1 M acetate buffer (pH 
4.5) was added to the reaction tubes and digestion was 
carried out at 37°C for 5 h. Samples were taken at various 
time intervals ranging from 0 to 360 min and digestion 
was terminated with an addition of 12 pL of 1 M Trisbase. 
The reaction mixture was centrifuged for 1Omin at 2000g 
and the Supernatant was subjected to total (Fab), 
determination. In a parallel experiment, pepsin-assisted 
enzymatic digestion was carried out with solution-phase 
Mab as a control (Johnstone and Thorpe (1987).
Determination of (Fab)2 in pepsin digest
Immulon I1 microtiter plates were coated with 100 pL per
well of 5 pg/mL diluted Fab specific murine antisera in 0.1 
M NaHC03 (pH 9.3) for 24 h at 4°C. The wells were
washed with TBS (0.05 M Tris-O.1 M NaCl) 0.05% Tween
and the residual reactive sites were blocked with TBS-O. 
1% polyethylene glycol (PEG) (MW 17 OOO) for 10 min 
at RT. Various dilutions of (Fab), standard and 
supernatants from pepsin digest in TBS-O.176 PEG were 
added to the wells, Following incubation the wells were 
washed four times and 1000-fold diluted HRP conjugated 
goat-anti-mouse IgG was added to the wells and 
incubated for 20 min at 37°C. 100 µL in each well, and 
incubated for 20 min at 37°C. The wells were washed 
four times and 100 pL of OPD substrate were added to 
each well. The colorimetric reaction was stopped after 3-5 
min by the addition of la0 pL of 1.5 M H2S04 to each well. 
Bound chromophore was detected at 490nm using a Bio-
Tek EL308 microplate reader.
Results
Modification of the reactive primary amines
The number of available reactive primary amines on rhPC
were modified by covalent and irreversible reaction with 
an ester. The extent of covalent modification was 
determined by the ability of modified rhPC to react with 
TNBS. The primary amines on proteins react with TNBS 
to yield a TNBS-protein complex which absorbs at 420 
nm and the absorbance is directly proportional to the 
available reactive primary amines on the protein. Figure 2 
shows the linear range of rhPC (native)-TNBS and 
modified rhPC-TNBS assay signals. The extent of 
modification was estimated from the ratio of the slopes of 
the modified rhPC to that of rhPC (native). Thus, the 
extent of covalent modification was estimated to be about 
60+2%.
Antigen binding experiments
The relative binding stabilities of immunocomplexes
formed in solution from unmodified and modified rhPC 
and native hPC from plasma with 8861-Mab were 
screened by ELISA (Subramanian et al., 1994). The rhPC 
was immunopurified to 95% purity by randomly coupled 
8861-Mab (Morcol et al., 1994). Figure 3 presents the 
ELISA signal of immunosorbed rhPC-8861 -Mab (native or 
modified) complex which had been first formed in solution 
and then immunocaptured. In general, the ELISA signal of 
unmodified rhPC- and hPC-8861-Mab complexes showed
Immobilization of Mab in the presence of FMA gave lower
Figure2. Reactivity of rhPC (native) and modified rhPC with TNBS. The 
extent of modification of the amino residues on rhPC was determined 
by TNBS assay (Velander et a/., 1992). Serial dilutions of native and 
modified rhPC were incubated with 0.03 M TNBS for 30 min at RT. 
Absorbances of the samples were read at 420 nm againt a reagent 
blank (assay buffer alone). The percentage modification was 
determined from the ratio of the slopes of the respective calibration 
graphs.
similar increases with increasing antigen concentration. 
The ELISA profile of the modified rhPC showed a slightly 
higher signal than unmodified rhPC and hPC at antigen to
Mab molar stoichiometries of 1:l and 2:l. The profile was 
otherwise similar for modified rhPC (FMA), rhPC and hPC
with a sharp maximum at a 6:l molar ratio of antigen to
Mab (Subramanian et al., 1994).
Effect of FMA on immobilization of Mab
Table 1 gives the coupling efficiencies obtained for 
masked and unmasked immunosorbents using Affi-prep 
or Emphaze AB1. Masking of the Mab was achieved with 
FMA (modified rhPC). Prior to covalent immobilization, 
FMA was incubated with 8861-Mab at a molar ratio of 6:l.
Figure 3. Antigen binding experiments. Increasing concentrations of 
hPC and rhPC were incubated with 8861-Mab at 1 h at 25°C and then 
added to rabbit anti-hPC-coated wells. After 1 h of incubation at 37"C, 
goat-anti-mouse IgG HRP conjugate was added to the wells and 
incubated for 1 h. The hPC or rhPC- 8861-Mab complex was detected 
and quantified with OPD and reading at 490 nm.
coupling efficiencies than Mab immobilized in the 
absence of FMA on both Affiprep and Emphaze AB1 
(Table 1). These masked Mabs were incubated at 2-3-fold 
higher
concentrations to achieve similar average densities. 
Immobilization of unmasked and masked 8861-Mab on 
Affi-prep gave absolute Mab coupling efficiencies of 60-t 
4% and 51 *3%, respectively, yielding 0.4 mg Mab/mL of 
support. Immobilization of unmasked 8861-Mab on 
Emphaze AB1 gave Mab coupling efficiencies of 9722% 
and 94i3%,
yielding 0.5 and 1.0 mg Mab/mL of support, respectively.
Immobilization of masked 8861-Mab on Emphaze AB1
gave Mab coupling efficiencies of 6624% and 52i3%,
yielding 0.7 and 1.1 mg Mab/mL of support, respectively. 
In the calculation of relative coupling efficiencies, a 100%
value was assigned to unmasked immunosorbents. Thus, 
the presence of the FMA reduced the relative coupling
efficiency of the Mab by about 15% for Affi-prep and
3045% for Emphaze AB 1.
Leaching of Mab
Prior to testing the immunosorbent capacity, three 
proteinfree but otherwise identical sequences of buffers 
used in the course of immunosorption chromatography 
were passed columnwise and all buffer streams were 
assayed for leached Mab and rhPC by EIAELISA. All 
product peaks from immunosorbent chromatography were 
assayed for leached Mab by EIA. Less than 0.3 ng 
Mab/mg rhPC was detected in product eluates from 
unmasked or masked, EMPHAZE AB1 or Affiprep 
immunosorbents.
Antigen binding efficiency (qAJo f immobilized Mabs
Antigen binding efficiencies of 8861-Mab immobilized on
either Emphaze AB1 or Affiprep were evaluated by
breakthrough analysis. Figure 4 shows typical 
breakthrough and elution profiles at 280nm for rhPC 
loaded on both masked and unmasked 8861 -Mab 
immunosorbent columns on either Emphaze AB1 or 
Affiprep. The shapes of the breakthrough profiles and 2 M 
naSCN elution peaks were similar for FMA-masked and 
unmasked 8861-Mab immunosorbents. The peak area 
under 2~ NaSCN eluate
fractions for FMA-masked immunosorbents were 2-3-fold
higher than those for immunosorbents made with 
unmasked 8861-Mab at comparable Mab densities. The 
Ag values of immobilized 8861-Mab on Emphaze ABl 
and Affiprep based on the amount of antigen in the 
product eluents from breakthrough loading are presented 
in Table 2. Immobilization of unmasked and masked 
8861-Mab on
Affiprep at 0.4 mg Mab/mL of gel gave Ag o f 18±3% and
48 2 5%, respectively. Immobilization of 'unmasked 8861-
Mab on Emphaze AB1 at 0.5 and 1.0 mg Mab/mL of
support gave (n,) of 2022% and 1923%, respectively.
Immobilization of masked 8861-Mab on Emphaze AB1 at
0.7 and 1.1 mg Mab/mL of support gave (Ag) of 44±4%
and 42±5%, respectively.
(Fab)2 Release by pepsin treatment of immunosorbents
Under acidic conditions, pepsin enzymatically cleaves an
intact IgG molecule at the hinge region to yield a (Fab), 
and Fc fragment. Figure 5 represents the time-dependent 
release of (Fab)2
presence of FMAs are consistent with an appreciable 
stearic shielding of reactive lysyl groups on the Mab by 
the FMA. The general inertness of the FMA was indicated 
by both the nearly quantitative recovery of the treated 
rhPC after immobilization and the lack of rhPC release 
from matrix during subsequent conditioning washes, 
which included harsh conditions such as 2 M NaSCN. The 
stability of the Mab-matrix linkages formed from 
unmasked and masked Mab was not appreciably different 
as judged by the similarly minimal release of Mab from 
either unmasked or masked immunosorbents into past-
coupling conditioning washes or product eluates. The 
lower reactivity of the masked Mab may have allowed 
greater permeation of the Mab into the matrix before 
coupoling. Therefore, a greater spatial distribution of Mab 
could have resulted throughout the matrix and thus
altered the intraparticle transport phenomena relative to 
that of unmasked Mab. Analysis of rhPC breakthrough 
curves on immunosorbents made with masked or 
unmasked Mab
Figure 5. Enzymatic digestion of unmasked and FMA-masked
immunosorbents. 100 pL of immunosorbents in 0.1 M sodium
citrate (pH 4.2) were incubated at 37°C with 80 pg of pepsin.
Samples were taken at the time intervals indicated and
quenched with 1 M Tris base (pH 8.6). Supernatants were
assayed for total [Fabl by ELISA.
did not exhibit any discernible differences in the 
breakthrough loading or elution profiles and thus mass 
transport phenomena. Further, although we did not 
directly investigate the intraparticle immobilization profile 
resulting from masked Mab, our previous work with the 
controlled
intraparticle distribution of unmasked Mab on Emphaze
AB 1 indicated that no significant mass transfer 
differences occur for a broad range of intraparticle Mab 
spatial
distributions at immobilized loadings of about 1-12 mg
Mab/mL matrix (Subramanian et al., 1994). The low bead 
average density of Mab used here showed little impact on 
( f)o r couplings with unmasked Mab and is consistent 
with a density regime where Mab crowding is not a chief 
cause of the loss of activity (Tharakan et al., 1990; 
Velander et al., 1992; Subramanian et al., 1994).
However, it is possible that the presence of the 
FMAshielding could also affect local Mab crowding under
conditions where the local Mab densities would be higher.
We are continuing to study these combined effects of 
locally high Mab density and improper orientation. The 
higher amount of (Fab),/mg immobilized Mab released by 
pepsin treatment of immunosorbents prepared with 
masked Mab relative to unmasked Mab correlated well
with the respective increases in (Ag)B. oth Emphaze AB1
and Affiprep immunosorbents prepared using FMA-
masked Mab gave a 2-3-fold higher (Ag)a nd a 34fold 
higher total pepsin-mediated (Fab), release relative to 
immunosorbents prepared with unmasked Mab. 
Furthermore, the similarity of the kinetic profiles of the 
time-dependent release of (Fab), for either masked or 
unmasked Mab is consistent with oriented Mab acting as 
a pepsin substrate and independent of whether the 
orientation resulted from a random or directed coupling 
process. The similar adsorptiorddesorption kinetic 
signatures detected by breakthrough antigen loading and 
elution profiles between random and directed coupling 
processes indicate that increases in (Ag) re probably not 
attributable to allosterically created conformations 
resulting from the presence of the mask in the binding 
sites of the (Fab), domain during coupling. This lack of 
difference in kinetic signature shown in Fig. 3 includes 
both antigen association under loading conditions and 
dissocation under washing and elution conditions. In 
terms of kinetics, the adsorption step of the 
immunosorption process for the oriented antibody can be 
interpreted as having a much larger association rate
relative to the unoriented Mab. Properly oriented Mab 
may be found in either unmasked or masked produced 
immunosorbents, but to a much lesser extent in 
immunosorbents made from unmasked Mab. In summary, 
the kinetics of the unoriented Mab appear to be so slow 
as to be turned off relative to an oriented Mab, Estimation 
of the sizes of FMAs studied in this and our past work 
suggest that effective masks should approach the size of 
the antigen combining site on the Fab fragment of an IgG 
molecule. Our previous work with synthetic FMA showed 
that larger masks of about 5-12kDa gave higher increases 
in relative efficiency and a greater correlation with the 
accessibility of Fab domains (Eveleigh and Levy, 1977).
Assuming similar globular behavior, the size of the Fab
domain on an IgG molecule (45kDa) and rhPC-FMA (62 
ma) can be expected to be similar on a molecular level,
which is about 2-3 nm (Sarma el af., 1971; Novotny et al.,
1983).
Conclusions
Our exepriments have shown that a greater degree of
random coupling of the protein to the matrix occurs when
the Mab is unmasked and that oriented coupling occurs
when the Mab is masked with FMA. We have shown
quantitatively that orientation plays a primary role in
immunosorbent activity where orientation phenomena 
may be impacting about 50% of the immobilized Mab 
functionality. FMAs can be used to increase the 
percentage of functional antibody relative to that obtained 
using random
covalent attachment without altering the Mab or the 
support matrix. The orientation phenomena achieved by 
masking the immunoglobulin prior to immobilization 
appear to be independent of the surface activation 
chemistry and support matrix.
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